ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glassman, A.
Right arrow Articles by Zagryn, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glassman, A.
Right arrow Articles by Zagryn, S.
Annals of Clinical and Laboratory Science, Vol 28, Issue 1, 24-29
Copyright © 1998 by Association of Clinical Scientists


Articles

Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemia

AB Glassman, EA Harper-Allen, KJ Hayes, VL Hopwood, EE Gutterman, and SP Zagryn

Chronic lymphocytic leukemia (CLL) is most characteristically associated with the cytogenetic abnormalities +12, 13q14, and 14q32. Recently abnormalities of chromosome 6 have been reported in patients with mantle zone lymphoma, CLL mixed type, and a CLL variant with larger prolymphocytoid cells in the peripheral blood. The purpose of this study was to review the cases of CLL karyotyped at the University of Texas M. D. Anderson Cancer Center (UTMDACC) and to determine the number and type of chromosome 6 abnormalities. Precisely 830 cases of CLL with karyotypes were reviewed. Among these, 257/830 (31 percent) had abnormal karyotypes, 56/257 (22 percent) had an abnormality of 6, 18/56 (32 percent) had translocations involving 6 and, in most instances, a different chromosome was involved, 37/56 (66 percent) had deletion 6 or loss of at least a portion of 6q, and 9/56 (16 percent) had an abnormality of 6p. The losses of 6q were in the q13 to q25 regions. Of these, 13/56 (23.2 percent) of patients with 6q abnormalities had > or = 10 percent prolymphocytes (PL) in the bone marrow (BM) and/or peripheral blood (PB), 10/56 (17.9 percent) had > or = 10 percent PL in the bone marrow, 8/56 (14.3 percent) had > or = 10 percent PL in the peripheral blood, and 5/56 (9 percent) had > or = 10 percent PL in both (see table I). The 201 CLL patients with chromosome abnormalities other than 6 contained 23 with excess PL (11.9 percent). A subset of karyotypic changes of 6 associated with increased PL is recognizable and may be useful in aiding in clinical diagnosis and therapy.


This article has been cited by other articles:


Home page
Cancer Res.Home page
P. B. Sinclair, A. Sorour, M. Martineau, C. J. Harrison, W. A. Mitchell, E. O'Neill, and L. Foroni
A Fluorescence in Situ Hybridization Map of 6q Deletions in Acute Lymphocytic Leukemia: Identification and Analysis of a Candidate Tumor Suppressor Gene
Cancer Res., June 15, 2004; 64(12): 4089 - 4098.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Association of Clinical Scientists.